A detailed history of Schroder Investment Management Group transactions in Incyte Corp stock. As of the latest transaction made, Schroder Investment Management Group holds 12,557 shares of INCY stock, worth $892,174. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,557
Previous 54,127 76.8%
Holding current value
$892,174
Previous $3.28 Million 74.7%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$57.33 - $68.61 $2.38 Million - $2.85 Million
-41,570 Reduced 76.8%
12,557 $830,000
Q2 2024

Aug 12, 2024

SELL
$51.18 - $63.75 $9.24 Million - $11.5 Million
-180,447 Reduced 76.93%
54,127 $3.28 Million
Q1 2024

May 14, 2024

SELL
$56.55 - $66.59 $7.53 Million - $8.86 Million
-133,113 Reduced 36.2%
234,574 $13.4 Million
Q4 2023

Feb 13, 2024

BUY
$52.16 - $64.19 $18.7 Million - $23 Million
358,272 Added 3805.33%
367,687 $23.1 Million
Q3 2023

Nov 14, 2023

BUY
$57.77 - $65.93 $751 - $857
13 Added 0.14%
9,415 $543,000
Q2 2023

Aug 11, 2023

BUY
$60.95 - $75.51 $155,849 - $193,079
2,557 Added 37.36%
9,402 $585,000
Q1 2023

May 11, 2023

SELL
$70.23 - $86.01 $63,768 - $78,097
-908 Reduced 11.71%
6,845 $494,000
Q4 2022

Feb 10, 2023

BUY
$67.18 - $84.11 $25,528 - $31,961
380 Added 5.15%
7,753 $622,000
Q3 2022

Nov 10, 2022

BUY
$66.18 - $82.86 $16,412 - $20,549
248 Added 3.48%
7,373 $492,000
Q2 2022

Aug 11, 2022

SELL
$66.18 - $83.18 $52,083 - $65,462
-787 Reduced 9.95%
7,125 $540,000
Q1 2022

May 16, 2022

SELL
$66.02 - $79.71 $194,230 - $234,506
-2,942 Reduced 27.11%
7,912 $631,000
Q4 2021

Feb 14, 2022

SELL
$63.34 - $74.11 $1.02 Million - $1.19 Million
-16,064 Reduced 59.68%
10,854 $797,000
Q3 2021

Nov 12, 2021

SELL
$68.67 - $84.02 $12.9 Million - $15.8 Million
-187,877 Reduced 87.47%
26,918 $1.85 Million
Q2 2021

Aug 13, 2021

BUY
$79.87 - $87.53 $13 Million - $14.2 Million
162,235 Added 308.67%
214,795 $18.1 Million
Q1 2021

May 17, 2021

BUY
$76.02 - $100.5 $3.58 Million - $4.73 Million
47,045 Added 853.04%
52,560 $4.27 Million
Q3 2020

Nov 13, 2020

SELL
$85.07 - $109.69 $1.16 Million - $1.5 Million
-13,680 Reduced 71.27%
5,515 $490,000
Q2 2020

Aug 13, 2020

BUY
$74.18 - $108.93 $1.17 Million - $1.71 Million
15,739 Added 455.41%
19,195 $2 Million
Q1 2020

May 15, 2020

SELL
$63.18 - $85.97 $758,160 - $1.03 Million
-12,000 Reduced 77.64%
3,456 $294,000
Q4 2017

Feb 09, 2018

BUY
$93.56 - $116.6 $1.45 Million - $1.8 Million
15,456
15,456 $1.46 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.8B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.